Scott et al. [143] observed elevated protein levels of ATG3, LC3, and Beclin 1 as well as a decrease in SQSTM1/p62 as early as seven days following the treatment of colorectal cancer cell lines with cabozantinib [143]. This evidence concerns the gene SQSTM1 and colorectal cancer.